During differentiation and oncogenic transformation the structures of complex carbohydrates on the cell surface change as a result of a modulation of the levels of glycosyltransferases. Many monoclonal antibodies which detect differentiation or transformation antigens are directed against these carbohydrates. Of 325 monoclonal antibodies that we have obtained from different laboratories, 97 bind carbohydrates (Table I) . Cell-surface carbohydrates can exist in either glycoproteins or glycolipids and in many cases identical oligosaccharides are found on both types of molecules. As glycolipids have a relatively simple structure and contain one hapten oligosaccharide. they are ideal for the chemical characterization of cell-surface-carbohydrate antigens.
A gastrointestinal cuncer-associated antigen detected by monoclonal antibocly 19-9 is a ganglioside-containing sialylated lacto-N_Jucopentaose I I in colorectal carcinoma cell line S W 1116
Monoclonal antibody 19-9, produced by hybridomas obtained from mice immunized with a human colon adenocarcinoma cell line, has an apparent specificity for human intestinal tumours (Koprowski et al., 1979) . Binding of this
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antibody to tumour cells is inhibited by serum from most patients with pancreatic and gastrointestinal cancer, but not by the serum of normal individuals, patients with inflammatory bowel diseases, or most patients with other malignancies (Herlyn el al., 1982) . The antigen for this antibody in the cell line used for immunization is a monosialoganglioside and was purified with the aid of a method we developed that allows the visualization of glycolipid antigens by direct binding of radioactive antibodies to thin-layer chromatograms followed by autoradiography (Magnani et al.. 1981 . About 30pg of ganglioside antigen is obtained from 1 g wet weight of tissue culture cells.
The structure of the carbohydrate was determined by methylation analysis, and combined gas chromatography and mass spectroscopy of the trifluoroacetylated derivative . to be:
NeuNaccx2-3Galfl-3GlcNAcfll-4Glc 4
Fuccll

I
This is a sialylated derivative of the normal Lei' blood group-active pentasaccharide, lacto-N-fucopentaose I I. Both fucose and sialic acid are immunodominant sugars as neither lacto-N-fucopentaose I1 nor LS-tetrasaccharide a (the defucosylated sialyloligosaccharide) bind the antibody. 
NeuNacu2-3Galfll -3GlcNac
Sialylated lacto-N-fucopentaose ZI is present on a mucin in patient's sera and in normal saliva Although the sialylated Lea sequence of sugars occurs in the gangliosides of pancreatic and gastrointestinal cancers, most of the antigen detected in the sera of patients are mucins (high molecular weight, carbohydrate-rich glycoproteins). The evidence (Magnani et al.. 1983) for this is as follows. Little antigen is extracted by organic solvents from sera and that which is remains at the origin under conditions of thin-layer chromatography where the ganglioside antigen migrates up the plate. Upon gel filtration of serum on Sephacryl S-400, the antigen elutes in the void volume, indicating an M , 2 5 x lo6. Incubation for 5 h at 35°C in 0.1 MNaOH destroys the serum antigen but does not affect the ganglioside antigen. The density of the serum antigen as determined in a CsCl gradient is 1.50g/ml, while in 4M-guanidine/HCl its density is 1.43g/ml. Finally, antigen affinity-purified by anti-(sialylated Lea) antibody from the serum of a cancer patient belonging to the Le(a -b +) blood group contains Leb antigen, consistent with the multiple antigenic specificities exhibited by mucins. The occurrence of mucins in the blood of cancer patients has been reported many times (Race & Sanger, 1975) .
In a previous study , sialylated Lea antigen was not detected by solid-phase radioimmunoassay in eltracts from normal adult tissues. By immunoperoxidase labelling of normal tissue sections, however, the antigen was found in a layer of ductal cells in normal pancreas and a layer of cells in normal salivary glands and bronchial epithelium that secrete mucins (Atkinson et al., 1982) , and by autoradiography low levels of ganglioside antigen were detected in extracts of normal pancreas (Hansson et al., 1983) . The antigen is also found in salivary mucins from blood group because they lack the fucosyltransferase that catalyses the synthesis of the sugar sequence Fucctl-4GlNac.. . (Grollman et af., 1969) . As a consequence, cancer patients belonging to the Le(a-b -) blood group cannot synthesize sialylated Lea antigen . There is more antigen in mucins from individuals belonging to the Le(A + b -) blood group than in mucins from individuals belonging to the Le(a -b + ) blood group. This is probably due to a competition between the glycosyltransferase that produces the Leb structure and that which produces sialylated Lea structure for the same acceptor oligosaccharide. Thus data on the presence of sialylated Lea oligosaccharide in sera of cancer patients detected by monoclonal antibody 19-9 should be categorized with respect to Lewis blood group status.
Many monoclonal antibodies which detect differentiation antigens and apparent tumour-associated antigens are directed against a carbohydrate sequence found in lacto-N-fucopentaose zzz Another carbohydrate antigen which occurs on both glycoproteins and glycolipids is remarkably immunogenic to mice and rats. As shown in Table 1 , about one sixth of the antibodies tested are directed against a sugur sequence found in the human milk oligosaccharide lacto-N-fucopentaose I1 . A glycolipid containing lacto-N-fucopentaose I11 was first isolated from a human adenocarcinoma (Yang & Hakomori, 1971) . The same sugar sequence minus the glycosyl residue occurs in higher glycolipids (Hakomori et al., 1982) and also in glycoproteins (Lloyd et al., 1968) . Antibodies against this sugar sequence detect a stage-specific embryonal antigen (called SSEA-1) of the murine embryo and teratocarcinoma (Gooi et al., 1981; Hakomori et af., 1982) ; they also detect an antigen (called My-1) that is strongly expressed in human granulocytes and granulocyte precursor cells but not in normal peripheral blood lymphocytes, monocytes, platelets and erythrocytes (Huang et af., 1983) , and they also detect an antigen characteristic of human small cell carcinoma, (Picard et al., 1978; Feizi, 1979; Kapadia et al., 1981a) , (c) a marker of human colon adenocarcinoma (Brown et al., 1983) , (d) an antigenic marker of human foetal endoderm (Williams et al., 1982) , (e) distinctive markers of human granulocytes amongst cells of the peripheral blood (Rumpold et al., 1982; Brown et al., 1983) , (f) differentiation antigens of human breast epithelium (Foster et at., 1982) , (g) stage-specific embryonic antigen of mouse (Solter & Knowles, 1978) and (h) a marker of the primary endoderm of the mouse (Kapadia et al., 19816) . All these antigenic markers are carbohydrate structures carried on various glycoproteins and glycolipids of the cell surface (Feizi, 1981a (Feizi, , 1982a  Table 1 ). They belong to a family of carbohydrate structures which also includes the major blood group antigens A, B, H, Lea and Leb, (see Figs. 2 and 3) .
